Venturi Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-8,355
| Closed | -$213K | – | 627 |
|
|
2025
Q3 | $213K | Buy |
+8,355
| New | +$206K | 0.01% | 532 |
|
|
2025
Q1 | – | Sell |
-6,181
| Closed | -$164K | – | 1473 |
|
|
2024
Q4 | $164K | Buy |
6,181
+1,159
| +23% | +$31.4K | 0.01% | 597 |
|
|
2024
Q3 | $145K | Sell |
5,022
-1,132
| -18% | -$33K | 0.01% | 487 |
|
|
2024
Q2 | $172K | Buy |
6,154
+3,197
| +108% | +$88K | 0.01% | 431 |
|
|
2024
Q1 | $82K | Sell |
2,957
-4,480
| -60% | -$124K | 0.01% | 439 |
|
|
2023
Q4 | $214K | Sell |
7,437
-999
| -12% | -$30.2K | 0.02% | 344 |
|
|
2023
Q3 | $280K | Sell |
8,436
-24,001
| -74% | -$849K | 0.02% | 303 |
|
|
2023
Q2 | $1.19M | Sell |
32,437
-179,302
| -85% | -$6.98M | 0.1% | 121 |
|
|
2023
Q1 | $8.64M | Buy |
211,739
+12,671
| +6% | +$547K | 0.71% | 36 |
|
|
2022
Q4 | $10.2M | Sell |
199,068
-11,151
| -5% | -$535K | 0.9% | 24 |
|
|
2022
Q3 | $9.2M | Sell |
210,219
-6,518
| -3% | -$317K | 0.88% | 23 |
|
|
2022
Q2 | $11.4M | Buy |
216,737
+634
| +0.3% | +$32.3K | 1.01% | 17 |
|
|
2022
Q1 | $11.2M | Buy |
216,103
+180,044
| +499% | +$9.34M | 0.86% | 26 |
|
|
2021
Q4 | $2.13M | Buy |
36,059
+5,147
| +17% | +$255K | 0.16% | 85 |
|
|
2021
Q3 | $1.33M | Buy |
30,912
+338
| +1% | +$15K | 0.11% | 116 |
|
|
2021
Q2 | $1.2M | Buy |
+30,574
| New | +$1.19M | 0.11% | 136 |
|
|
2020
Q3 | – | Sell |
-21,425
| Closed | -$665K | – | 296 |
|
|
2020
Q2 | $665K | Sell |
21,425
-214,957
| -91% | -$7.3M | 0.09% | 149 |
|
|
2020
Q1 | $7.32M | Buy |
236,382
+71,445
| +43% | +$2.43M | 1.25% | 27 |
|
|
2019
Q4 | $6.13M | Sell |
164,937
-45,395
| -22% | -$1.62M | 0.74% | 43 |
|
|
2019
Q3 | $7.17M | Buy |
210,332
+13,800
| +7% | +$502K | 0.92% | 41 |
|
|
2019
Q2 | $8.08M | Sell |
196,532
-11,358
| -5% | -$451K | 1.09% | 37 |
|
|
2019
Q1 | $8.45M | Buy |
207,890
+14,306
| +7% | +$573K | 1.1% | 31 |
|
|
2018
Q4 | $7.72M | Buy |
193,584
+5,585
| +3% | +$232K | 1.25% | 16 |
|
|
2018
Q3 | $7.9M | Buy |
187,999
+2,429
| +1% | +$93.5K | 1.4% | 18 |
|
|
2018
Q2 | $7.22M | Buy |
185,570
+6,200
| +3% | +$212K | 1.35% | 15 |
|
|
2018
Q1 | $6.04M | Buy |
179,370
+6,416
| +4% | +$221K | 1.17% | 27 |
|
|
2017
Q4 | $5.94M | Buy |
172,954
+6,057
| +4% | +$207K | 1.14% | 29 |
|
|
2017
Q3 | $5.71M | Sell |
166,897
-18,313
| -10% | -$589K | 1.21% | 24 |
|
|
2017
Q2 | $5.9M | Sell |
185,210
-32,421
| -15% | -$1.02M | 1.34% | 25 |
|
|
2017
Q1 | $6.99M | Buy |
217,631
+23,369
| +12% | +$737K | 1.62% | 21 |
|
|
2016
Q4 | $5.99M | Buy |
194,262
+18,519
| +11% | +$565K | 1.68% | 24 |
|
|
2016
Q3 | $5.65M | Buy |
175,743
+2,092
| +1% | +$70K | 1.88% | 19 |
|
|
2016
Q2 | $5.8M | Buy |
173,651
+5,837
| +3% | +$186K | 1.97% | 12 |
|
|
2016
Q1 | $4.72M | Buy |
167,814
+39,822
| +31% | +$1.14M | 1.76% | 19 |
|
|
2015
Q4 | $3.92M | Buy |
+127,992
| New | +$4.03M | 1.78% | 23 |
|
Other funds holding PFE
Venturi Wealth Management's PFE Position: Q4 2025 in Review
Venturi Wealth Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 8,355 shares — an estimated $213K sold.
Venturi Wealth Management first reported a position in PFE in Q4 2015 and held it in 35 quarters. The position peaked at $11.4M in Q2 2022. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Venturi Wealth Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Venturi Wealth Management sold 8,355 Pfizer shares in Q4 2025, an estimated $213K.
- Venturi Wealth Management first reported a position in Pfizer in Q4 2015 and held it in 35 quarters.
- Venturi Wealth Management's Pfizer position peaked at $11.4M in Q2 2022.
- 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Venturi Wealth Management's 13F filing for Q4 2025, filed 22 Jan 2026.